Researchers conducted a multicenter study to see if a personalized approach could improve results for adults with rheumatoid arthritis. In the tailored group, doctors chose the first medication based on whether the patient had specific autoantibodies. The other group received standard care regardless of those antibodies. Both groups received steroid treatment and extra check-ins at months one and four.
The study followed 308 patients over a period of 10 months. Results showed that both groups had similar disease activity levels throughout the study. Additionally, there was no significant difference in how many patients required advanced biologic treatments after ten months.
Safety profiles were similar between both groups, with no differences in adverse events reported. Because this was an open-label trial, it is important to note that results may be influenced by the fact that doctors knew which treatment plan each patient received. Currently, these findings suggest that adding autoantibody checks to the standard treatment strategy does not change clinical outcomes.
Common questions
Does testing for autoantibodies change how rheumatoid arthritis is treated?
In this study of 308 adults, using a tailored approach based on autoantibody status did not result in better clinical outcomes compared to routine care. Both groups showed similar disease activity levels over the 10-month period. You should speak with your doctor about how these findings apply to your specific treatment plan.
Were there any safety concerns with the tailored treatment approach?
The study reported no differences in adverse events between the group receiving tailored care and the group receiving routine care. Both groups received similar steroid bridging and follow-up schedules. Because this was an open-label trial, some factors may influence how results are interpreted.
How many people needed advanced treatments in each group?
At the 10-month mark, 21% of patients in the tailored group required synthetic or biologic DMARDs, while 17% in the routine care group did. However, this difference was not statistically significant, meaning both methods performed similarly over the course of the study.
